PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine

Song Guo,Charlotte Ernstsen,Anders Hay-Schmidt,Messoud Ashina,Jes Olesen,Sarah Louise Christensen

DOI: https://doi.org/10.1186/s10194-022-01523-8

2022-12-06

Abstract:Calcitonin gene-related peptide (CGRP) antagonizing drugs represents the most important advance in migraine therapy for decades. However, these new drugs are only effective in 50–60% of patients. Recent studies have shown that the pituitary adenylate cyclase-activating peptide (PACAP38) pathway is independent from the CGRP signaling pathway. Here, we investigate PACAP38 signaling pathways in relation to glyceryl trinitrate (GTN), levcromakalim and sumatriptan.

neurosciences,clinical neurology